Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A combination of diclofenac potassium, a nonsteroidal anti-inflammatory drug (NSAID), and dinoprostone, a prostaglandin E2. This combination is used for pain management during medical procedures, particularly hysterosalpingography (HSG) in infertile patients. Diclofenac potassium provides analgesic and anti-inflammatory effects by inhibiting cyclooxygenase enzymes, while dinoprostone facilitates cervical ripening and softening.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on diclofenac potassium + dinoprostone.